Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.22ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.22ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.22EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.22EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.22ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.22ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.521EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.521EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.521ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.521ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.521EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.521EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.521ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.521ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.378EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.378EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.378ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.378ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.378EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.378EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.378ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.378ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.206EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.206EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.206ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.206ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.206EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.206EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.206ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.206ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.28EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.28ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.28ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.28EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.28EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.28ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.28ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.9EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CM.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.9ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
CM.9ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CM.9EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CM.9EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CM.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CM.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.4.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.4.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.4.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used